Drug firm Glenmark Pharmaceuticals today said it has received approval from the US Food and Drug Administration (FDA) for an ointment used in treating skin problems.
The company had filed an abbreviated new drug application, which is for generic drugs only.
The company has got the approval through its US-based subsidiary Glenmark Generics and will launch the product in the US market immediately, Glenmark said in a filing to the Bombay Stock Exchange.
"Today's approval (complements) Glenmark's recent launch of Alcometasone Dipropionate cream and allows the company to provide superior service to their customers by offering complete line of Alclometasone topical products," the filing said.
Alcometasone Dipropionate is a generic version of GSK's Aclovate and the company will manufacture it at its US FDA approved manufacturing facility in Baddi, Himachal Pradesh.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app